IL-1-receptor Antagonist During Cephalic Phase of Insulin Secretion in Health and Type 2 Diabetes

Clinical trial NCT04227769 · TERMINATED

Trial details

NCT number: NCT04227769
Sponsor: University Hospital, Basel, Switzerland
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus Type 2 in Obese Inflammation Metabolic Disease Glucose Metabolism Disorders (Including Diabetes Mellitus)

Start date: 2020-01-13
Primary completion: 2024-05-28
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.